Enovix (NASDAQ:ENVX) Releases Q1 2026 Earnings Guidance

Enovix (NASDAQ:ENVX) issued an update on its first quarter 2026 earnings guidance on Wednesday morning. The company provided EPS guidance of -0.180–0.140 for the period, compared to the consensus EPS estimate of -0.190. The company issued revenue guidance of $6.5 million-$7.5 million, compared to the consensus revenue estimate of $8.8 million.

Analysts Set New Price Targets

Several brokerages recently commented on ENVX. Canaccord Genuity Group lowered their price objective on Enovix from $22.00 to $21.00 and set a “buy” rating on the stock in a research report on Thursday, November 6th. Northland Securities set a $16.00 price objective on Enovix in a research report on Monday, November 17th. Weiss Ratings restated a “sell (d-)” rating on shares of Enovix in a research note on Monday, December 29th. Oppenheimer set a $24.00 price target on shares of Enovix in a research note on Thursday, November 6th. Finally, JPMorgan Chase & Co. lowered their price objective on shares of Enovix from $12.00 to $10.00 and set a “neutral” rating on the stock in a research report on Wednesday, November 12th. Five equities research analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $17.50.

Enovix Price Performance

ENVX traded up $0.04 during trading on Wednesday, hitting $6.15. 7,620,218 shares of the company traded hands, compared to its average volume of 6,354,530. The company has a market cap of $1.33 billion, a PE ratio of -7.59 and a beta of 2.13. Enovix has a 1 year low of $5.27 and a 1 year high of $16.49. The company has a current ratio of 9.72, a quick ratio of 9.47 and a debt-to-equity ratio of 1.74. The stock’s 50-day simple moving average is $7.21 and its two-hundred day simple moving average is $8.98.

Enovix (NASDAQ:ENVX) last issued its quarterly earnings data on Wednesday, February 25th. The company reported ($0.14) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.17) by $0.03. Enovix had a negative return on equity of 61.78% and a negative net margin of 525.93%.Enovix has set its Q1 2026 guidance at -0.180–0.140 EPS. As a group, sell-side analysts anticipate that Enovix will post -1.01 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Enovix

A number of hedge funds and other institutional investors have recently bought and sold shares of the company. Parallel Advisors LLC lifted its holdings in Enovix by 51.9% in the third quarter. Parallel Advisors LLC now owns 3,926 shares of the company’s stock valued at $39,000 after acquiring an additional 1,342 shares during the last quarter. Wilmington Savings Fund Society FSB acquired a new position in shares of Enovix in the third quarter valued at approximately $80,000. Mercer Global Advisors Inc. ADV acquired a new stake in shares of Enovix in the third quarter valued at $100,000. Mackenzie Financial Corp acquired a new stake in Enovix in the 4th quarter valued at about $77,000. Finally, CIBC Asset Management Inc acquired a new stake in Enovix in the fourth quarter valued at approximately $78,000. Hedge funds and other institutional investors own 50.92% of the company’s stock.

Enovix Company Profile

Enovix Corporation (NASDAQ: ENVX) develops and manufactures advanced lithium-ion battery cells with a patented three-dimensional silicon-anode architecture. The company’s core focus is on delivering high energy density, improved safety, and longer cycle life compared to conventional graphite-based cells. Enovix’s technology targets a range of applications, including consumer electronics, wearable devices, electric vehicles and stationary energy storage systems.

Founded in 2011 and headquartered in Fremont, California, Enovix has built pilot production capability and is scaling up manufacturing capacity to meet growing demand.